The study focused on activation of lymphocytes derived from healthy donors and cancer patients in the medium supplemented with IL-2 and IL-15 at low concentrations. We studied morphological features of cultured cells, their viability, and proliferative and functional activities during culturing for up to 14 days. In comparison with lymphocytes derived from cancer patients, white blood cells derived from healthy donors demonstrated a number of advantages under the given culturing conditions such as higher viability, greater proliferative activity, and the potency for earlier activation; moreover, during activation they secreted the anti-inflammatory cytokines IL-4 and IL-10 at greater concentrations.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abakushina EV, Marizina YV, Kaprin AD. Morphofunctional Characteristics of Human Lymphocytes after In Vitro Activation. Bull. Exp. Biol. Med. 2016;161(5):731-735.
Abakushina EV, Marizina YuV, Neprina GS. Efficiency of IL-2 and IL-15 combined use for activation of cytotoxic lymphocytes in vitro. Geny Kletki. 2015;10(2):78-85. Russian.
Volkov NM. Cell-based anticancer immunotherapy methods. Prakt. Onkol. 2016;17(2):90-98. Russian.
Kadagidze ZG. Cytokines. Prakt. Onkol. 2003;4(3):131-139. Russian.
Kaprin AD, Galkin VN, Zhavoronkov LP, Ivanov VK, Ivanov SA, Romanko YuS. Synthesis of basic and applied research is the basis of obtaining high-quality findings and translating them into clinical practice. Radiatsiya Risk. 2017;26(2):26-40. Russian.
Nuriev RI, Karaulov AV, Kisielewski MV. Novel treatment strategies for patients with cancer: immunotherapeutic approach. Immunologia. 2017;38(1):39-48. Russian.
Kaprin AD, Abakushina EV, Marizina JV, Neprina GS. Patent RU No. 2603079. Method of cytogenetic activation of human lymphocytes. Bull. No. 32. Published November 20, 2016.
Simbirtsev AS. Cytokines - classification and biologic functions. Tsitokiny Vospalenie. 2004;3(2):16-22. Russian.
Yurova KA, Khaziakhmatova OG, Todosenko NM, Litvinova LS. Effects of γc-cytokines (IL-2, IL-7, and IL-15) on maturation and differentiation of CD45RО+CD4+/CD8+Т cells in vitro. Med. Immunol. 2018;20(1):45-52. Russian.
Cany J, Dolstra H, Shah N. Umbilical cord blood-derived cellular products for cancer immunotherapy. Cytotherapy. 2015;17(6):739-748.
Granzin M, Wagner J, Köhl U, Cerwenka A, Huppert V, Ullrich E. Shaping of natural killer cell antitumor activity by ex vivo cultivation. Front. Immunol. 2017;8. ID 458. doi:https://doi.org/10.3389/fimmu.2017.00458.
Gras Navarro A, Björklund AT, Chekenya M. Therapeutic potential and challenges of natural killer cells in treatment of solid tumors. Front. Immunol. 2015;6. ID 202. doi: https://doi.org/10.3389/fimmu.2015.00202.
Waldmann TA. The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design. Nat. Rev. Immunol. 2006;6(8):595-601.
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 167, No. 4, pp. 471-477, April, 2019
Rights and permissions
About this article
Cite this article
Gel’m, Y.V., Kuz’mina, E.G. & Abakushina, E.V. Functional Activity of Lymphocytes of Healthy Donors and Cancer Patients After Culturing with IL-2 and IL-15. Bull Exp Biol Med 167, 486–491 (2019). https://doi.org/10.1007/s10517-019-04556-3
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-019-04556-3